111 related articles for article (PubMed ID: 16352005)
1. The heart as a target for oestrogens.
Brown L; Hoong I; Doggrell SA
Heart Lung Circ; 2000 Dec; 9(3):113-25. PubMed ID: 16352005
[TBL] [Abstract][Full Text] [Related]
2. Effects of phyto-oestrogens on tissues.
Anderson JJ; Anthony M; Messina M; Garne SC
Nutr Res Rev; 1999 Jun; 12(1):75-116. PubMed ID: 19087447
[TBL] [Abstract][Full Text] [Related]
3. Cellular mechanisms underlying the cardiovascular actions of oestrogens.
Ling S; Komesaroff P; Sudhir K
Clin Sci (Lond); 2006 Aug; 111(2):107-18. PubMed ID: 16831130
[TBL] [Abstract][Full Text] [Related]
4. The value of phytoestrogens as a possible therapeutic option in postmenopausal women with coronary heart disease.
Finking G; Hess B; Hanke H
J Obstet Gynaecol; 1999 Sep; 19(5):455-9. PubMed ID: 15512363
[TBL] [Abstract][Full Text] [Related]
5. [Is primary, secondary or tertiary prevention of coronary heart disease possible by means of oestrogens or gestagens?].
Husmann F
Zentralbl Gynakol; 2002 Apr; 124(4):194-7. PubMed ID: 12080479
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol and atherosclerosis: modulation by oestrogen.
Barton M
Curr Opin Lipidol; 2013 Jun; 24(3):214-20. PubMed ID: 23594711
[TBL] [Abstract][Full Text] [Related]
7. Understanding the oestrogen action in experimental and clinical atherosclerosis.
Arnal JF; Douin-Echinard V; Brouchet L; Tremollières F; Laurell H; Lenfant F; Gadeau AP; Guery JC; Gourdy P
Fundam Clin Pharmacol; 2006 Dec; 20(6):539-48. PubMed ID: 17109647
[TBL] [Abstract][Full Text] [Related]
8. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
Bonkhoff H; Berges R
Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
[TBL] [Abstract][Full Text] [Related]
9. Oestrogens and puberty.
Alonso LC; Rosenfield RL
Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):13-30. PubMed ID: 11987895
[TBL] [Abstract][Full Text] [Related]
10. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343
[TBL] [Abstract][Full Text] [Related]
12. Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways.
Leung SW; Teoh H; Keung W; Man RY
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):822-6. PubMed ID: 17600565
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene, tamoxifen and vascular tone.
Leung FP; Tsang SY; Wong CM; Yung LM; Chan YC; Leung HS; Yao X; Huang Y
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):809-13. PubMed ID: 17600563
[TBL] [Abstract][Full Text] [Related]
15. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
16. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.
Mori TA; Woodman RJ
Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):95-104. PubMed ID: 16477172
[TBL] [Abstract][Full Text] [Related]
17. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
[TBL] [Abstract][Full Text] [Related]
18. Sex hormones and the cardiovascular system: effects on arterial function in women.
Teede HJ
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
[TBL] [Abstract][Full Text] [Related]
19. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
Lakoski SG; Herrington DM
Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
[TBL] [Abstract][Full Text] [Related]
20. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
Gungor F; Kalelioglu I; Turfanda A
Angiology; 2009; 60(3):308-17. PubMed ID: 18505742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
